Innocan Pharma Corp banner

Dividends

Innocan Pharma Corp
does not pay dividends

Shareholder Yield

Current shareholder yield for INNO is hidden .

Shareholder Yield
LOCKED
Unlock
What is shareholder yield?
Dividend Yield
No dividends
Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Price Appreciation

INNO Price
Innocan Pharma Corp

Annual Price Range
1.8
52w Low
1.8
52w High
18.5
Price Metrics
Average Annual Return 591.23%
Standard Deviation of Annual Returns 1 397.94%
Max Drawdown -91%
Shares Statistics
Market Capitalization 8.1m CAD
Shares Outstanding 4 500 000
Percentage of Shares Shorted 0.7%

INNO Return Decomposition
Main factors of price return

Stock Splits

INNO's latest stock split occurred on Sep 5, 2025

The company executed a 1-for-65 stock split, meaning that for every 65 shares held, investors received 1 new share.

Before the split, INNO traded at 12.35 per share. Afterward, the share price was about 13.

The adjusted shares began trading on Sep 5, 2025. This was the only stock split in INNO's history.

Pre-Split Price
12.35 12.35
Post-Split Price
13
Before
After